Methyl 6-(4-bromo-2-fluoroanilino)-7-fluoro-3H-benzimidazole-5-carboxylateis a useful pharmaceutical intermediate for the synthesis of N3 alkylated benzimidazole derivatives as inhibitors of mitogen-activated protein kinase kinase (MEK), e.g. Binimetinib (MEK162, ARRY-162) as a MEK, or more specifically, a MAP2K inhibitor.
Not a dangerous goods
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Available on request.
Please inquire for pricing and availability of this product by writing email email@example.com.